Conmed Corp (NYSE:CNMD)
$ 74.76 -0.88 (-1.16%) Market Cap: 2.31 Bil Enterprise Value: 3.24 Bil PE Ratio: 17.76 PB Ratio: 2.47 GF Score: 75/100

Q1 2022 Conmed Corp Earnings Call Transcript

May 04, 2022 / 08:30PM GMT
Release Date Price: $139.43 (+3.77%)
Operator

Good day, and thank you for standing by. Welcome to the First Quarter Fiscal Year '22 CONMED Earnings Conference Call. (Operator Instructions) After today's presentation, there will be an opportunity to ask questions. (Operator Instructions)

With us today are Curt Hartman, President and CEO; and Todd Garner, Executive Vice President and Chief Financial Officer.

I would like to now turn the conference over to CONMED. Please note this conference is being recorded.

Unidentified Company Representative

Good afternoon, everyone. Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook and its plans and objectives, which represent forward-looking statements that involve risks and uncertainties as those terms are defined under the federal securities laws. Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results, and the company's actual results may differ materially from its current

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot